SCHEMBL20106743

SCHEMBL20106743

O=C(N(C1CC1)C1CC2(CCNCC2)C1)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20106858 0.84 P2RY14 (0.30)
SCHEMBL15507272 0.81 SLC6A4 (0.39)
Hydrochloric Acid SCHEMBL22797965 0.80 SLC6A4 (0.38)
SCHEMBL21088978 0.75 KDM4E (0.34)
SCHEMBL25924019 0.72
SCHEMBL20106862 0.71
SCHEMBL20106745 0.71 ITGB3 (0.30)
SCHEMBL21088402 0.70
SCHEMBL21088890 0.70 NR1I2 (0.30)
SCHEMBL20106999 0.70 CYP3A4 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3532459-B1 LSD1 INHIBITORS AND MEDICAL USES THEREOF CONSTELLATION PHARMACEUTICALS INC (US) 2023-08-02 EP disclosed
EP-3286172-B1 LSD1 INHIBITORS AND USES THEREOF CONSTELLATION PHARMACEUTICALS INC (US) 2019-06-12 EP disclosed
WO-2018081343-A1 LSD1 INHIBITORS AND MEDICAL USES THEREOF CONSTELLATION PHARMACEUTICALS, INC. (US) 2018-05-03 WO disclosed